BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 33752763)

  • 1. Laptop-Administered NIH Toolbox and Cogstate Brief Battery in Community-Dwelling Black Adults: Unexpected Pattern of Cognitive Performance between MCI and Healthy Controls.
    Kairys A; Daugherty A; Kavcic V; Shair S; Persad C; Heidebrink J; Bhaumik A; Giordani B
    J Int Neuropsychol Soc; 2022 Mar; 28(3):239-248. PubMed ID: 33752763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computerized Cognitive Testing for Use in Clinical Trials: A Comparison of the NIH Toolbox and Cogstate C3 Batteries.
    Buckley RF; Sparks KP; Papp KV; Dekhtyar M; Martin C; Burnham S; Sperling RA; Rentz DM
    J Prev Alzheimers Dis; 2017; 4(1):3-11. PubMed ID: 29188853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mild Cognitive Impairment Subtype Performance in Comparison to Healthy Older Controls on the NIH Toolbox and Cogstate.
    Garcia S; Askew RL; Kavcic V; Shair S; Bhaumik AK; Rose E; Campbell S; May N; Hampstead BM; Dodge HH; Heidebrink JL; Paulson HL; Giordani B
    Alzheimer Dis Assoc Disord; 2023 Oct-Dec 01; 37(4):328-334. PubMed ID: 37862614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical validity of the Italian adaptation of the Uniform Data Set Neuropsychological Test Battery (I-UDSNB) in Mild Cognitive Impairment and Alzheimer's Disease.
    Conca F; Esposito V; Catricalà E; Manenti R; L'Abbate F; Quaranta D; Giuffrè GM; Rossetto F; Solca F; Orso B; Inguscio E; Crepaldi V; De Matteis M; Rotondo E; Manera M; Caruso G; Catania V; Canu E; Rundo F; Cotta Ramusino M; Filippi M; Fundarò C; Piras F; Arighi A; Tiraboschi P; Stanzani Maserati M; Pardini M; Poletti B; Silani V; Marra C; Di Tella S; Cotelli M; Lodi R; Tagliavini F; Cappa SF
    Alzheimers Res Ther; 2024 May; 16(1):98. PubMed ID: 38704608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitivity of Individual and Composite Test Scores from the Cogstate Brief Battery to Mild Cognitive Impairment and Dementia Due to Alzheimer's Disease.
    White JP; Schembri A; Prenn-Gologranc C; Ondrus M; Katina S; Novak P; Lim YY; Edgar C; Maruff P
    J Alzheimers Dis; 2023; 96(4):1781-1799. PubMed ID: 38007647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validity of a brief computerized cognitive screening test in dementia.
    Hammers D; Spurgeon E; Ryan K; Persad C; Barbas N; Heidebrink J; Darby D; Giordani B
    J Geriatr Psychiatry Neurol; 2012 Jun; 25(2):89-99. PubMed ID: 22689701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of Diffusion Modeling of Cogstate Brief Battery Test Performance in Detecting Mild Cognitive Impairment.
    Mulhauser K; Giordani B; Kavcic V; May LDN; Bhaumik A; Shair S; Votruba K
    Assessment; 2023 Apr; 30(3):847-855. PubMed ID: 35016575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive consequences of high Aβ amyloid in mild cognitive impairment and healthy older adults: implications for early detection of Alzheimer's disease.
    Lim YY; Ellis KA; Harrington K; Kamer A; Pietrzak RH; Bush AI; Darby D; Martins RN; Masters CL; Rowe CC; Savage G; Szoeke C; Villemagne VL; Ames D; Maruff P;
    Neuropsychology; 2013 May; 27(3):322-332. PubMed ID: 23688214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construct validation of NIH Toolbox Cognition Battery premorbid cognitive functioning scores in Black and White older Americans with and without mild cognitive impairment.
    Halter CM; Moll AC; Kero K; Kavcic V; Woodard JL; Giordani B
    J Int Neuropsychol Soc; 2024 Feb; 30(2):194-198. PubMed ID: 37477003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interpreting Patterns of Low Scores on the NIH Toolbox Cognition Battery.
    Holdnack JA; Tulsky DS; Brooks BL; Slotkin J; Gershon R; Heinemann AW; Iverson GL
    Arch Clin Neuropsychol; 2017 Aug; 32(5):574-584. PubMed ID: 28419177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Convergent and criterion validity of the CogState computerized brief battery cognitive assessment in women with and without breast cancer.
    Patel SK; Meier AM; Fernandez N; Lo TTY; Moore C; Delgado N
    Clin Neuropsychol; 2017 Nov; 31(8):1375-1386. PubMed ID: 28080264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychometric Evaluation of the Neuropsychological Test Battery in Individuals with Normal Cognition, Mild Cognitive Impairment, or Mild to Moderate Alzheimer's Disease: Results from a Longitudinal Study.
    Harrison JE; Rentz DM; Brashear HR; Arrighi HM; Ropacki MT; Liu E
    J Prev Alzheimers Dis; 2018; 5(4):236-244. PubMed ID: 30298182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Brief Computerized Paired Associate Test for the Detection of Mild Cognitive Impairment in Community-Dwelling Older Adults.
    Curiel RE; Crocco E; Rosado M; Duara R; Greig MT; Raffo A; Loewenstein DA
    J Alzheimers Dis; 2016 Sep; 54(2):793-9. PubMed ID: 27567839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Face-Name Associative Recognition Deficits in Subjective Cognitive Decline and Mild Cognitive Impairment.
    Polcher A; Frommann I; Koppara A; Wolfsgruber S; Jessen F; Wagner M
    J Alzheimers Dis; 2017; 56(3):1185-1196. PubMed ID: 28106560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropsychological Impairments and Their Cognitive Architecture in Mild Cognitive Impairment (MCI) with Lewy Bodies and MCI-Alzheimer's Disease.
    Ciafone J; Thomas A; Durcan R; Donaghy PC; Hamilton CA; Lawley S; Roberts G; Colloby S; Firbank MJ; Allan L; Petrides G; Taylor JP; O'Brien JT; Gallagher P
    J Int Neuropsychol Soc; 2022 Oct; 28(9):963-973. PubMed ID: 34666864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using the NIH Toolbox to Assess Cognition in Adolescents and Young Adults with Autism Spectrum Disorders.
    Solomon M; Gordon A; Iosif AM; Geddert R; Krug MK; Mundy P; Hessl D
    Autism Res; 2021 Mar; 14(3):500-511. PubMed ID: 33006263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations between Performance on an Abbreviated CogState Battery, Other Measures of Cognitive Function, and Biomarkers in People at Risk for Alzheimer's Disease.
    Racine AM; Clark LR; Berman SE; Koscik RL; Mueller KD; Norton D; Nicholas CR; Blennow K; Zetterberg H; Jedynak B; Bilgel M; Carlsson CM; Christian BT; Asthana S; Johnson SC
    J Alzheimers Dis; 2016 Oct; 54(4):1395-1408. PubMed ID: 27589532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Latent Factor Structure and Measurement Invariance of the NIH Toolbox Cognition Battery in an Alzheimer's Disease Research Sample.
    Ma Y; Carlsson CM; Wahoske ML; Blazel HM; Chappell RJ; Johnson SC; Asthana S; Gleason CE
    J Int Neuropsychol Soc; 2021 May; 27(5):412-425. PubMed ID: 33012297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baseline characterization of the ARMADA (Assessing Reliable Measurement in Alzheimer's Disease) study cohorts.
    Karpouzian-Rogers T; Ho E; Novack M; Chinkers M; Bedjeti K; Nowinski C; Giordani B; Gershon R; Weintraub S
    Alzheimers Dement; 2023 May; 19(5):1974-1982. PubMed ID: 36396612
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.